Bevacizumab in Treating Patients With Recurrent or Progressive Glioma

Clinical trial NCT00337207 · COMPLETED

Trial details

NCT number: NCT00337207
Sponsor: Northwestern University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors

Start date: 2006-03-01
Primary completion: 2008-11-01
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.